...
机译:Remdesivir,Lopinavir,emetine和Homoharingtonine在体外抑制SARS-COV-2复制
Univ Hong Kong LKS Fac Med Sch Publ Hlth Hong Kong Peoples R China;
Univ Hong Kong LKS Fac Med Sch Publ Hlth Hong Kong Peoples R China;
Univ Hong Kong LKS Fac Med Sch Publ Hlth Hong Kong Peoples R China;
Univ Hong Kong LKS Fac Med Sch Publ Hlth Hong Kong Peoples R China;
Univ Hong Kong LKS Fac Med Sch Publ Hlth Hong Kong Peoples R China;
Univ Hong Kong LKS Fac Med Sch Publ Hlth Hong Kong Peoples R China;
Univ Hong Kong LKS Fac Med Sch Publ Hlth Hong Kong Peoples R China;
Univ Hong Kong LKS Fac Med Sch Publ Hlth Hong Kong Peoples R China;
Hong Kong Univ Sci &
Technol Dept Chem Hong Kong Peoples R China;
Hong Kong Univ Sci &
Technol Dept Chem Hong Kong Peoples R China;
Univ Hong Kong LKS Fac Med Sch Publ Hlth Hong Kong Peoples R China;
Univ Hong Kong LKS Fac Med Sch Publ Hlth Hong Kong Peoples R China;
COVID-19; Remdesivir; Lopinavir; Ritonavir; Emetine; Homoharringtonine;
机译:Remdesivir,Lopinavir,emetine和Homoharingtonine在体外抑制SARS-COV-2复制
机译:Artemisia Annua L.提取物抑制SARS-COV-2的体外复制和其两种变体
机译:通过结合保守的NSP9 SARS-COV-2蛋白,天然产品化合物在体外抑制冠状病毒复制
机译:洛匹那韦的口服递送聚合物纳米颗粒:体外和离体研究的开发和统计优化
机译:Picornavirus复制平台的结构:抑制病毒复制的潜在药物靶标
机译:伦德昔韦洛匹那韦依美丁和高灵顿碱在体外抑制SARS-CoV-2复制
机译:Remdesivir,Lopinavir,Emetine和Homoharingtonine在体外抑制SARS-COV-2复制
机译:蛋白质aDp-核糖基化的细胞调节。 3.体内依美舒治疗后小鼠胸腺细胞中组蛋白H3的体外aDp-核糖基化的选择性增强。